70 related articles for article (PubMed ID: 36996606)
1. Human papillomavirus associated XPF deficiency increases alternative end joining and cisplatin sensitivity in head and neck squamous cell carcinoma.
Zuo N; Ma L; Liu T; Hu W; Luo Y; Meng H; Ren Q; Deng Y; Wei L; Liu Q
Oral Oncol; 2023 May; 140():106367. PubMed ID: 36996606
[TBL] [Abstract][Full Text] [Related]
2. FAK Drives Resistance to Therapy in HPV-Negative Head and Neck Cancer in a p53-Dependent Manner.
Pifer PM; Yang L; Kumar M; Xie T; Frederick M; Hefner A; Beadle B; Molkentine D; Molkentine J; Dhawan A; Abdelhakiem M; Osman AA; Leibowitz BJ; Myers JN; Pickering CR; Sandulache VC; Heymach J; Skinner HD
Clin Cancer Res; 2024 Jan; 30(1):187-197. PubMed ID: 37819945
[TBL] [Abstract][Full Text] [Related]
3. Human Papillomavirus and Risk of Head and Neck Squamous Cell Carcinoma in Iran.
Karimi A; Mohebbi E; Mckay-Chopin S; Rashidian H; Hadji M; Peyghambari V; Marzban M; Naghibzadeh-Tahami A; Gholipour M; Kamangar F; Tommasino M; Gheit T; Zendehdel K
Microbiol Spectr; 2022 Aug; 10(4):e0011722. PubMed ID: 35708339
[TBL] [Abstract][Full Text] [Related]
4. Preclinical Evaluation of the ATR Inhibitor BAY 1895344 as a Radiosensitizer for Head and Neck Squamous Cell Carcinoma.
Odhiambo DA; Pittman AN; Rickard AG; Castillo RJ; Bassil AM; Chen J; Ravotti ML; Xu ES; Himes JE; Daniel AR; Watts TL; Williams NT; Luo L; Kirsch DG; Mowery YM
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1315-1327. PubMed ID: 38104870
[TBL] [Abstract][Full Text] [Related]
5. Deciphering head and neck cancer microenvironment: Single-cell and spatial transcriptomics reveals human papillomavirus-associated differences.
Lee H; Park S; Yun JH; Seo C; Ahn JM; Cha HY; Shin YS; Park HR; Lee D; Roh J; Heo HJ; Baek SE; Kim EK; Lee HS; Kim CH; Kim YH; Jang JY
J Med Virol; 2024 Jan; 96(1):e29386. PubMed ID: 38235919
[TBL] [Abstract][Full Text] [Related]
6. Immune microenvironment of human papillomavirus-positive head and neck squamous cell carcinoma.
Zhu D; He X; Li Y; Li G; Chen M
Sci Prog; 2024; 107(1):368504241237888. PubMed ID: 38545800
[TBL] [Abstract][Full Text] [Related]
7. Differential Regulation of the STING Pathway in Human Papillomavirus-Positive and -Negative Head and Neck Cancers.
Saulters EL; Kennedy PT; Carter RJ; Alsufyani A; Jones TM; Woolley JF; Dahal LN
Cancer Res Commun; 2024 Jan; 4(1):118-133. PubMed ID: 38147007
[TBL] [Abstract][Full Text] [Related]
8. The role of Glial cell derived neurotrophic factor in head and neck cancer.
Cao H; He Q; Eyben RV; Bloomstein J; Nambiar DK; Viswanathan V; Aggarwal S; Kwok S; Liang R; Koong AJ; Lewis JS; Kong C; Xiao N; Le QT
PLoS One; 2020; 15(2):e0229311. PubMed ID: 32084217
[TBL] [Abstract][Full Text] [Related]
9. β-CATENIN is a positive prognostic marker for HPV-positive head and neck squamous cell carcinoma.
Stoiber S; Brkic FF; Maier T; Schnoell J; Gurnhofer E; Heiduschka G; Kadletz-Wanke L; Kenner L
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7743-7750. PubMed ID: 37010585
[TBL] [Abstract][Full Text] [Related]
10. Noncanonical HPV carcinogenesis drives radiosensitization of head and neck tumors.
Schrank TP; Kothari A; Weir WH; Stepp WH; Rehmani H; Liu X; Wang X; Sewell A; Li X; Tasoulas J; Kim S; Yarbrough G; Xie Y; Flamand Y; Marur S; Hayward MC; Wu D; Burtness B; Anderson KS; Baldwin AS; Yarbrough WG; Issaeva N
Proc Natl Acad Sci U S A; 2023 Aug; 120(32):e2216532120. PubMed ID: 37523561
[TBL] [Abstract][Full Text] [Related]
11. CHD4 acts as a prognostic factor and drives radioresistance in HPV negative HNSCC.
Geyer F; Geyer M; Reuning U; Klapproth S; Wolff KD; Nieberler M
Sci Rep; 2024 Apr; 14(1):8286. PubMed ID: 38594331
[TBL] [Abstract][Full Text] [Related]
12. Combined IL6 and CCR2 blockade potentiates antitumor activity of NK cells in HPV-negative head and neck cancer.
Yang F; Yuan C; Chen F; Qin ZS; Schmitt NC; Lesinski GB; Saba NF; Teng Y
J Exp Clin Cancer Res; 2024 Mar; 43(1):76. PubMed ID: 38468260
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy combined with docetaxel alters the immune phenotype of HNSCC cells and results in increased surface expression of CD137 and release of HMGB1 of specifically HPV-positive tumor cells.
Grottker F; Gehre S; Reichardt CM; Sengedorj A; Jost T; Rieckmann T; Hecht M; Gostian AO; Frey B; Fietkau R; Gaipl US; Rückert M
Neoplasia; 2023 Nov; 45():100944. PubMed ID: 37857049
[TBL] [Abstract][Full Text] [Related]
14. The dual role of autophagy in HPV-positive head and neck squamous cell carcinoma: a systematic review.
Kandathil SA; Akhondi A; Kadletz-Wanke L; Heiduschka G; Engedal N; Brkic FF
J Cancer Res Clin Oncol; 2024 Jan; 150(2):56. PubMed ID: 38291202
[TBL] [Abstract][Full Text] [Related]
15. A novel ΔNp63-dependent immune mechanism improves prognosis of HPV-related head and neck cancer.
Mourtada J; Lony C; Nicol A; De Azevedo J; Bour C; Macabre C; Roncarati P; Ledrappier S; Schultz P; Borel C; Burgy M; Wasylyk B; Mellitzer G; Herfs M; Gaiddon C; Jung AC
Front Immunol; 2023; 14():1264093. PubMed ID: 38022675
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumor cell abundance in head and neck squamous cell carcinoma decreases with successful chemoradiation and cetuximab treatment.
Poellmann MJ; Bu J; Kim D; Iida M; Hong H; Wang AZ; Wheeler DL; Kimple RJ; Hong S
Cancer Lett; 2023 May; 562():216187. PubMed ID: 37068555
[TBL] [Abstract][Full Text] [Related]
17. MEDI0457 Plus Durvalumab in HPV-associated HNSCC-Letter.
Mori K; Notsu A; Miura K; Onozawa Y
Clin Cancer Res; 2023 Jul; 29(14):2735. PubMed ID: 37449359
[No Abstract] [Full Text] [Related]
18. MEDI0457 Plus Durvalumab in HPV-associated HNSCC-Response.
Aggarwal C; Gong M; Kumar R
Clin Cancer Res; 2023 Jul; 29(14):2736. PubMed ID: 37449358
[No Abstract] [Full Text] [Related]
19. HPV/E7 induces chemotherapy-mediated tumor suppression by ceramide-dependent mitophagy.
Thomas RJ; Oleinik N; Panneer Selvam S; Vaena SG; Dany M; Nganga RN; Depalma R; Baron KD; Kim J; Szulc ZM; Ogretmen B
EMBO Mol Med; 2017 Aug; 9(8):1030-1051. PubMed ID: 28606997
[TBL] [Abstract][Full Text] [Related]
20. Exposure to Secondhand Smoke Extract Increases Cisplatin Resistance in Head and Neck Cancer Cells.
Sadhasivam B; Manyanga J; Ganapathy V; Acharya P; Bouharati C; Chinnaiyan M; Mehta T; Mathews B; Castles S; Rubenstein DA; Tackett AP; Zhao YD; Ramachandran I; Queimado L
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
